Cue Biopharma
Earnings Surprise
Analysts estimated CUE earnings of $-2.83 per share this quarter (Q3). CUE's actual earnings were $-2.10 per share.
CUE EPS surprise of 25.74%Analysts estimated CUE earnings of $-0.14 per share this quarter (Q2). CUE's actual earnings were $-0.09 per share.
CUE EPS surprise of 36.35%Analysts estimated CUE earnings of $-0.15 per share this quarter (Q1). CUE's actual earnings were $-0.17 per share.
CUE EPS surprise of -9.75%Analysts estimated CUE earnings of $-0.16 per share this quarter (Q4). CUE's actual earnings were $-0.13 per share.
CUE EPS surprise of 17.51%Analysts estimated CUE earnings of $-0.19 per share this quarter (Q3). CUE's actual earnings were $-0.17 per share.
CUE EPS surprise of 12.55%Analysts estimated CUE earnings of $-0.29 per share this quarter (Q2). CUE's actual earnings were $-0.20 per share.
CUE EPS surprise of 30.26%Analysts estimated CUE earnings of $-0.28 per share this quarter (Q1). CUE's actual earnings were $-0.25 per share.
CUE EPS surprise of 12.22%Analysts estimated CUE earnings of $-0.35 per share this quarter (Q3). CUE's actual earnings were $-0.24 per share.
CUE EPS surprise of -30.62%